These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1390332)

  • 1. Long-term hemodynamic effects of nifedipine on congenital heart disease with Eisenmenger's mechanism in children.
    Wimmer M; Schlemmer M
    Cardiovasc Drugs Ther; 1992 Apr; 6(2):183-6. PubMed ID: 1390332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative studies of hemodynamics under prostacyclin and nifedipine in patients with Eisenmenger syndrome].
    Gildein HP; Wildberg A; Mocellin R
    Z Kardiol; 1995 Jan; 84(1):55-63. PubMed ID: 7863716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease.
    Engelfriet PM; Duffels MG; Möller T; Boersma E; Tijssen JG; Thaulow E; Gatzoulis MA; Mulder BJ
    Heart; 2007 Jun; 93(6):682-7. PubMed ID: 17164490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy of sildenafil in Eisenmenger's syndrome secondary to atrial septal defect versus ventricular septal defect: a cardiac catheterisation follow-up study.
    Garg N; Tripathy N; Sinha N
    Cardiol Young; 2011 Dec; 21(6):631-8. PubMed ID: 21729508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of nifedipine in patients with Eisenmenger's syndrome complicating patency of the arterial duct.
    Wong CK; Lau CP; Leung WH; Cheng CH
    Int J Cardiol; 1989 Nov; 25(2):173-8. PubMed ID: 2807605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of pulmonary arterial hypertension associated with congenital systemic-to-pulmonary shunts and Eisenmenger's syndrome.
    Galie N; Manes A; Palazzini M; Negro L; Marinelli A; Gambetti S; Mariucci E; Donti A; Branzi A; Picchio FM
    Drugs; 2008; 68(8):1049-66. PubMed ID: 18484798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pulmonary hypertension in children with Down's syndrome and congenital heart disease. Is it really more severe?].
    Vázquez-Antona CA; Lomelí C; Buendía A; Vargas-Barrón J
    Arch Cardiol Mex; 2006; 76(1):16-27. PubMed ID: 16749498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of nifedipine and oxygen in children with pulmonary hypertension.
    Wimmer M; Schlemmer M; Ebner F
    Cardiovasc Drugs Ther; 1988 Dec; 2(5):661-8. PubMed ID: 3154641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute Effect of Inhaled Iloprost in Children with Pulmonary Arterial Hypertension Associated with Simple Congenital Heart Defects.
    Li Q; Dimopoulos K; Zhang C; Zhu Y; Liu Q; Gu H
    Pediatr Cardiol; 2018 Apr; 39(4):757-762. PubMed ID: 29426959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial septal defects versus ventricular septal defects in BREATHE-5, a placebo-controlled study of pulmonary arterial hypertension related to Eisenmenger's syndrome: a subgroup analysis.
    Berger RM; Beghetti M; Galiè N; Gatzoulis MA; Granton J; Lauer A; Chiossi E; Landzberg M
    Int J Cardiol; 2010 Oct; 144(3):373-8. PubMed ID: 19464064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute haemodynamic effects of nifedipine in patients with ventricular septal defect.
    Berisha S; Goda A; Kastrati A; Frasheri A; Popa Y
    Br Heart J; 1988 Aug; 60(2):149-55. PubMed ID: 3415874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early and late effects of surgical closure of ventricular septal defects on pulmonary vascular dynamics.
    Kawashima Y; Mori M
    Jpn Circ J; 1976 Jun; 40(6):637-43. PubMed ID: 950731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamic studies of nifedipine (Adalat) in pulmonary hypertension in childhood].
    Wimmer M; Schlemmer M; Ebner F
    Wien Klin Wochenschr; 1986 Nov; 98(21):740-3. PubMed ID: 3101292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.
    Brownlee JR; Beekman RH; Rosenthal A
    Pediatr Res; 1988 Aug; 24(2):186-90. PubMed ID: 3186330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lactobacillus paracasei endocarditis in an 18-yeard-old patient with trisomy 21, atrioventricular septal defect and Eisenmenger complex: therapeutic problems].
    Schmidt V; Wolter M; Lenschow U; Kienast W
    Klin Padiatr; 2001; 213(1):35-8. PubMed ID: 11225474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of hemodynamic changes with oxygen inhalation in VSD associated with pulmonary hypertension.
    Teramoto S; Fujiwara T; Takahara I
    Jpn Circ J; 1976 Jun; 40(6):623-7. PubMed ID: 950728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled nitric oxide in congenital heart disease.
    Roberts JD; Lang P; Bigatello LM; Vlahakes GJ; Zapol WM
    Circulation; 1993 Feb; 87(2):447-53. PubMed ID: 8425292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital heart disease in Down's syndrome.
    Laursen HB
    Br Heart J; 1976 Jan; 38(1):32-8. PubMed ID: 1252293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down's syndrome, complete atrioventricular canal, and pulmonary vascular obstructive disease.
    Clapp S; Perry BL; Farooki ZQ; Jackson WL; Karpawich PP; Hakimi M; Arciniegas E; Green EW; Pinsky WW
    J Thorac Cardiovasc Surg; 1990 Jul; 100(1):115-21. PubMed ID: 2142250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of Rho-kinase inhibitor fasudil on pulmonary arterial hypertension in patients with congenital heart defects.
    Xiao JW; Zhu XY; Wang QG; Zhang DZ; Cui CS; Zhang P; Chen HY; Meng LL
    Circ J; 2015; 79(6):1342-8. PubMed ID: 25797071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.